vs
Side-by-side financial comparison of OFG BANCORP (OFG) and Vericel Corp (VCEL). Click either name above to swap in a different company.
OFG BANCORP is the larger business by last-quarter revenue ($184.3M vs $92.9M, roughly 2.0× Vericel Corp). OFG BANCORP runs the higher net margin — 30.3% vs 25.0%, a 5.3% gap on every dollar of revenue. On growth, Vericel Corp posted the faster year-over-year revenue change (23.3% vs 0.9%). OFG BANCORP produced more free cash flow last quarter ($199.3M vs $12.8M). Over the past eight quarters, Vericel Corp's revenue compounded faster (34.6% CAGR vs 2.8%).
OFG Bancorp, founded in 1964, is the financial holding company for Oriental Bank, located in San Juan, Puerto Rico. OFG offers a wide range of retail and commercial banking, lending and wealth management products, services and technology, primarily in Puerto Rico and the U.S. Virgin Islands through its principal subsidiaries: Oriental Bank, Oriental Financial Services LLC, and Oriental Insurance LLC. Its headquarters are located at Oriental Center, 254 Muñoz Rivera Avenue, San Juan, PR 00918....
Vericel Corporation is a publicly traded American biopharmaceutical company which was known prior to October 2014 as Aastrom Bio. Aastrom Bio was formed in 1989 in Ann Arbor, Michigan.
OFG vs VCEL — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $184.3M | $92.9M |
| Net Profit | $55.9M | $23.2M |
| Gross Margin | — | 78.7% |
| Operating Margin | 25.7% | 24.1% |
| Net Margin | 30.3% | 25.0% |
| Revenue YoY | 0.9% | 23.3% |
| Net Profit YoY | 11.0% | 17.3% |
| EPS (diluted) | $1.27 | $0.46 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $184.3M | $92.9M | ||
| Q3 25 | $186.2M | $67.5M | ||
| Q2 25 | $182.4M | $63.2M | ||
| Q1 25 | $178.6M | $52.6M | ||
| Q4 24 | $182.7M | $75.4M | ||
| Q3 24 | $174.7M | $57.9M | ||
| Q2 24 | $179.8M | $52.7M | ||
| Q1 24 | $174.4M | $51.3M |
| Q4 25 | $55.9M | $23.2M | ||
| Q3 25 | $51.8M | $5.1M | ||
| Q2 25 | $51.8M | $-553.0K | ||
| Q1 25 | $45.6M | $-11.2M | ||
| Q4 24 | $50.3M | $19.8M | ||
| Q3 24 | $47.0M | $-901.0K | ||
| Q2 24 | $51.1M | $-4.7M | ||
| Q1 24 | $49.7M | $-3.9M |
| Q4 25 | — | 78.7% | ||
| Q3 25 | — | 73.5% | ||
| Q2 25 | — | 73.7% | ||
| Q1 25 | — | 69.0% | ||
| Q4 24 | — | 77.6% | ||
| Q3 24 | — | 71.9% | ||
| Q2 24 | — | 69.5% | ||
| Q1 24 | — | 68.9% |
| Q4 25 | 25.7% | 24.1% | ||
| Q3 25 | 33.0% | 5.1% | ||
| Q2 25 | 36.1% | -3.2% | ||
| Q1 25 | 33.3% | -24.3% | ||
| Q4 24 | 28.9% | 24.5% | ||
| Q3 24 | 35.4% | -4.3% | ||
| Q2 24 | 39.6% | -11.5% | ||
| Q1 24 | 38.9% | -10.7% |
| Q4 25 | 30.3% | 25.0% | ||
| Q3 25 | 27.8% | 7.5% | ||
| Q2 25 | 28.4% | -0.9% | ||
| Q1 25 | 25.5% | -21.4% | ||
| Q4 24 | 27.6% | 26.3% | ||
| Q3 24 | 26.9% | -1.6% | ||
| Q2 24 | 28.4% | -8.9% | ||
| Q1 24 | 28.5% | -7.5% |
| Q4 25 | $1.27 | $0.46 | ||
| Q3 25 | $1.16 | $0.10 | ||
| Q2 25 | $1.15 | $-0.01 | ||
| Q1 25 | $1.00 | $-0.23 | ||
| Q4 24 | $1.10 | $0.40 | ||
| Q3 24 | $1.00 | $-0.02 | ||
| Q2 24 | $1.08 | $-0.10 | ||
| Q1 24 | $1.05 | $-0.08 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $1.0B | $137.5M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $1.4B | $354.6M |
| Total Assets | $12.5B | $488.0M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $1.0B | $137.5M | ||
| Q3 25 | $740.3M | $135.4M | ||
| Q2 25 | $851.8M | $116.9M | ||
| Q1 25 | $710.6M | $112.9M | ||
| Q4 24 | $591.1M | $116.2M | ||
| Q3 24 | $680.6M | $101.7M | ||
| Q2 24 | $740.4M | $102.5M | ||
| Q1 24 | $754.4M | $110.6M |
| Q4 25 | $1.4B | $354.6M | ||
| Q3 25 | $1.4B | $321.9M | ||
| Q2 25 | $1.3B | $306.8M | ||
| Q1 25 | $1.3B | $295.5M | ||
| Q4 24 | $1.3B | $292.0M | ||
| Q3 24 | $1.3B | $257.5M | ||
| Q2 24 | $1.2B | $243.0M | ||
| Q1 24 | $1.2B | $233.9M |
| Q4 25 | $12.5B | $488.0M | ||
| Q3 25 | $12.2B | $453.3M | ||
| Q2 25 | $12.2B | $435.6M | ||
| Q1 25 | $11.7B | $424.6M | ||
| Q4 24 | $11.5B | $432.7M | ||
| Q3 24 | $11.5B | $390.4M | ||
| Q2 24 | $11.3B | $376.8M | ||
| Q1 24 | $11.2B | $356.7M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $217.7M | $15.0M |
| Free Cash FlowOCF − Capex | $199.3M | $12.8M |
| FCF MarginFCF / Revenue | 108.1% | 13.8% |
| Capex IntensityCapex / Revenue | 10.0% | 2.4% |
| Cash ConversionOCF / Net Profit | 3.90× | 0.65× |
| TTM Free Cash FlowTrailing 4 quarters | $345.4M | $24.7M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $217.7M | $15.0M | ||
| Q3 25 | $39.5M | $22.1M | ||
| Q2 25 | $35.9M | $8.2M | ||
| Q1 25 | $83.1M | $6.6M | ||
| Q4 24 | $252.5M | $22.2M | ||
| Q3 24 | $58.1M | $10.2M | ||
| Q2 24 | $95.1M | $18.5M | ||
| Q1 24 | $61.0M | $7.2M |
| Q4 25 | $199.3M | $12.8M | ||
| Q3 25 | $35.5M | $19.5M | ||
| Q2 25 | $31.8M | $81.0K | ||
| Q1 25 | $78.7M | $-7.6M | ||
| Q4 24 | $231.2M | $8.5M | ||
| Q3 24 | $51.8M | $-9.2M | ||
| Q2 24 | $90.4M | $1.8M | ||
| Q1 24 | $54.8M | $-6.8M |
| Q4 25 | 108.1% | 13.8% | ||
| Q3 25 | 19.1% | 28.8% | ||
| Q2 25 | 17.4% | 0.1% | ||
| Q1 25 | 44.1% | -14.5% | ||
| Q4 24 | 126.5% | 11.2% | ||
| Q3 24 | 29.6% | -15.9% | ||
| Q2 24 | 50.3% | 3.4% | ||
| Q1 24 | 31.4% | -13.3% |
| Q4 25 | 10.0% | 2.4% | ||
| Q3 25 | 2.1% | 3.9% | ||
| Q2 25 | 2.3% | 12.9% | ||
| Q1 25 | 2.4% | 27.0% | ||
| Q4 24 | 11.7% | 18.3% | ||
| Q3 24 | 3.6% | 33.5% | ||
| Q2 24 | 2.6% | 31.8% | ||
| Q1 24 | 3.5% | 27.3% |
| Q4 25 | 3.90× | 0.65× | ||
| Q3 25 | 0.76× | 4.35× | ||
| Q2 25 | 0.69× | — | ||
| Q1 25 | 1.82× | — | ||
| Q4 24 | 5.02× | 1.12× | ||
| Q3 24 | 1.24× | — | ||
| Q2 24 | 1.86× | — | ||
| Q1 24 | 1.23× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
OFG
Segment breakdown not available.
VCEL
| MACI Implants And Kits | $84.1M | 90% |
| Other | $8.8M | 10% |
